新华制药再获三个药品批件

动脉网
Nov 28, 2025

新华制药近日再获三个药品批件:自主研发的利丙双卡因乳膏获批上市,用于皮肤局部麻醉,2024年中国公立医疗机构销售额约6.15亿元,是公司今年第35个制剂产品批件、首个乳膏剂型产品;原料药醋酸泼尼松龙获批,主要用于过敏性与自身免疫性炎症疾病,2024年中国公立医疗机构相关制剂销售额约1亿元,是公司今年第5个原料药产品批件、又一激素类产品;盐酸肾上腺素注射液仿制药获批通过质量与疗效一致性评价,适用于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10